blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3199641

EP3199641 - MEANS AND METHODS FOR STAGING, TYPING AND TREATING A CANCEROUS DISEASE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  05.08.2022
Database last updated on 02.11.2024
FormerThe patent has been granted
Status updated on  27.08.2021
FormerGrant of patent is intended
Status updated on  06.04.2021
FormerExamination is in progress
Status updated on  15.06.2018
FormerRequest for examination was made
Status updated on  09.02.2018
FormerThe application has been published
Status updated on  04.07.2017
Most recent event   Tooltip13.09.2024Lapse of the patent in a contracting state
New state(s): MT
published on 16.10.2024  [2024/42]
Applicant(s)For all designated states
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
Hansastr. 27c
80686 München / DE
For all designated states
Universität Regensburg
Universitätsstrasse 31
93053 Regensburg / DE
[2022/16]
Former [2021/39]For all designated states
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
Hansastraße 27c
80686 München / DE
For all designated states
Universität Regensburg
Universitätsstrasse 31
93053 Regensburg / DE
Former [2017/31]For all designated states
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
Hansastraße 27c
80686 München / DE
For all designated states
Universität Regensburg
Universitätsstrasse 31
93053 Regensburg / DE
Inventor(s)01 / KLEIN, Christoph
Eichenstraße 12a
93049 Regensburg / DE
02 / SCHEITLER, Sebastian
Martin-Greif Straße 1
93051 Regensburg / DE
03 / WERNER-KLEIN, Melanie
Eichenstraße 12a
93049 Regensburg / DE
04 / HOFFMANN, Martin
Alte Nürnberger Straße 30
93059 Regensburg / DE
05 / HODAK, Isabelle
Jakob-Hagenbacher-Straße 10c
80993 München / DE
 [2017/31]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[2017/31]
Application number, filing date16152883.127.01.2016
[2017/31]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3199641
Date:02.08.2017
Language:EN
[2017/31]
Type: B1 Patent specification 
No.:EP3199641
Date:29.09.2021
Language:EN
[2021/39]
Search report(s)(Supplementary) European search report - dispatched on:EP15.07.2016
ClassificationIPC:C12Q1/68, C12Q1/6886, A61P35/00, A61P35/04, A61P43/00
[2021/14]
CPC:
C12Q1/6886 (EP,KR,US); A61P35/00 (EP); A61P35/04 (EP);
A61P43/00 (EP); C12Q2600/112 (EP,KR,US); C12Q2600/118 (EP,KR,US);
C12Q2600/156 (EP,KR,US) (-)
Former IPC [2017/31]C12Q1/68
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/11]
Former [2017/31]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:MITTEL UND VERFAHREN ZUR STADIUMBESTIMMUNG, TYPISIERUNG UND BEHANDLUNG EINER KREBSERKRANKUNG[2017/31]
English:MEANS AND METHODS FOR STAGING, TYPING AND TREATING A CANCEROUS DISEASE[2017/31]
French:MOYENS ET PROCÉDÉS PERMETTANT D'ÉVALUER L'ÉVOLUTION, DE SAISIR LES DONNÉES ET DE TRAITER UNE MALADIE CANCÉREUSE[2017/31]
Examination procedure27.01.2016Date on which the examining division has become responsible
31.01.2018Amendment by applicant (claims and/or description)
31.01.2018Examination requested  [2018/11]
15.06.2018Despatch of a communication from the examining division (Time limit: M06)
02.01.2019Reply to a communication from the examining division
20.03.2019Despatch of a communication from the examining division (Time limit: M06)
30.09.2019Reply to a communication from the examining division
06.04.2020Despatch of a communication from the examining division (Time limit: M04)
21.07.2020Reply to a communication from the examining division
19.10.2020Despatch of a communication from the examining division (Time limit: M02)
01.12.2020Reply to a communication from the examining division
07.04.2021Communication of intention to grant the patent
17.08.2021Fee for grant paid
17.08.2021Fee for publishing/printing paid
17.08.2021Receipt of the translation of the claim(s)
Opposition(s)30.06.2022No opposition filed within time limit [2022/36]
Fees paidRenewal fee
23.01.2018Renewal fee patent year 03
24.01.2019Renewal fee patent year 04
22.01.2020Renewal fee patent year 05
25.01.2021Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU27.01.2016
AL29.09.2021
AT29.09.2021
CY29.09.2021
CZ29.09.2021
DK29.09.2021
EE29.09.2021
FI29.09.2021
HR29.09.2021
LT29.09.2021
LV29.09.2021
MC29.09.2021
MK29.09.2021
MT29.09.2021
PL29.09.2021
RO29.09.2021
RS29.09.2021
SE29.09.2021
SI29.09.2021
SK29.09.2021
SM29.09.2021
BG29.12.2021
NO29.12.2021
GR30.12.2021
IE27.01.2022
LU27.01.2022
IS29.01.2022
BE31.01.2022
PT31.01.2022
[2024/42]
Former [2024/22]HU27.01.2016
AL29.09.2021
AT29.09.2021
CY29.09.2021
CZ29.09.2021
DK29.09.2021
EE29.09.2021
FI29.09.2021
HR29.09.2021
LT29.09.2021
LV29.09.2021
MC29.09.2021
MK29.09.2021
PL29.09.2021
RO29.09.2021
RS29.09.2021
SE29.09.2021
SI29.09.2021
SK29.09.2021
SM29.09.2021
BG29.12.2021
NO29.12.2021
GR30.12.2021
IE27.01.2022
LU27.01.2022
IS29.01.2022
BE31.01.2022
PT31.01.2022
Former [2024/21]HU27.01.2016
AL29.09.2021
AT29.09.2021
CY29.09.2021
CZ29.09.2021
DK29.09.2021
EE29.09.2021
FI29.09.2021
HR29.09.2021
LT29.09.2021
LV29.09.2021
MC29.09.2021
PL29.09.2021
RO29.09.2021
RS29.09.2021
SE29.09.2021
SI29.09.2021
SK29.09.2021
SM29.09.2021
BG29.12.2021
NO29.12.2021
GR30.12.2021
IE27.01.2022
LU27.01.2022
IS29.01.2022
BE31.01.2022
PT31.01.2022
Former [2024/20]HU27.01.2016
AL29.09.2021
AT29.09.2021
CY29.09.2021
CZ29.09.2021
DK29.09.2021
EE29.09.2021
FI29.09.2021
HR29.09.2021
LT29.09.2021
LV29.09.2021
MC29.09.2021
PL29.09.2021
RO29.09.2021
RS29.09.2021
SE29.09.2021
SI29.09.2021
SK29.09.2021
BG29.12.2021
NO29.12.2021
GR30.12.2021
IE27.01.2022
LU27.01.2022
IS29.01.2022
BE31.01.2022
PT31.01.2022
Former [2024/18]HU27.01.2016
AL29.09.2021
AT29.09.2021
CZ29.09.2021
DK29.09.2021
EE29.09.2021
FI29.09.2021
HR29.09.2021
LT29.09.2021
LV29.09.2021
MC29.09.2021
PL29.09.2021
RO29.09.2021
RS29.09.2021
SE29.09.2021
SI29.09.2021
SK29.09.2021
BG29.12.2021
NO29.12.2021
GR30.12.2021
IE27.01.2022
LU27.01.2022
IS29.01.2022
BE31.01.2022
PT31.01.2022
Former [2023/09]AL29.09.2021
AT29.09.2021
CZ29.09.2021
DK29.09.2021
EE29.09.2021
FI29.09.2021
HR29.09.2021
LT29.09.2021
LV29.09.2021
MC29.09.2021
PL29.09.2021
RO29.09.2021
RS29.09.2021
SE29.09.2021
SI29.09.2021
SK29.09.2021
BG29.12.2021
NO29.12.2021
GR30.12.2021
IE27.01.2022
LU27.01.2022
IS29.01.2022
BE31.01.2022
PT31.01.2022
Former [2023/01]AL29.09.2021
AT29.09.2021
CZ29.09.2021
DK29.09.2021
EE29.09.2021
FI29.09.2021
HR29.09.2021
LT29.09.2021
LV29.09.2021
MC29.09.2021
PL29.09.2021
RO29.09.2021
RS29.09.2021
SE29.09.2021
SI29.09.2021
SK29.09.2021
BG29.12.2021
NO29.12.2021
GR30.12.2021
LU27.01.2022
IS29.01.2022
BE31.01.2022
PT31.01.2022
Former [2022/46]AL29.09.2021
AT29.09.2021
CZ29.09.2021
DK29.09.2021
EE29.09.2021
FI29.09.2021
HR29.09.2021
LT29.09.2021
LV29.09.2021
MC29.09.2021
PL29.09.2021
RO29.09.2021
RS29.09.2021
SE29.09.2021
SK29.09.2021
BG29.12.2021
NO29.12.2021
GR30.12.2021
LU27.01.2022
IS29.01.2022
PT31.01.2022
Former [2022/39]AL29.09.2021
AT29.09.2021
CZ29.09.2021
DK29.09.2021
EE29.09.2021
FI29.09.2021
HR29.09.2021
LT29.09.2021
LV29.09.2021
MC29.09.2021
PL29.09.2021
RO29.09.2021
RS29.09.2021
SE29.09.2021
SK29.09.2021
BG29.12.2021
NO29.12.2021
GR30.12.2021
IS29.01.2022
PT31.01.2022
Former [2022/36]AL29.09.2021
AT29.09.2021
CZ29.09.2021
DK29.09.2021
EE29.09.2021
FI29.09.2021
HR29.09.2021
LT29.09.2021
LV29.09.2021
PL29.09.2021
RO29.09.2021
RS29.09.2021
SE29.09.2021
SK29.09.2021
BG29.12.2021
NO29.12.2021
GR30.12.2021
IS29.01.2022
PT31.01.2022
Former [2022/29]AL29.09.2021
AT29.09.2021
CZ29.09.2021
EE29.09.2021
FI29.09.2021
HR29.09.2021
LT29.09.2021
LV29.09.2021
PL29.09.2021
RO29.09.2021
RS29.09.2021
SE29.09.2021
SK29.09.2021
BG29.12.2021
NO29.12.2021
GR30.12.2021
IS29.01.2022
PT31.01.2022
Former [2022/24]AT29.09.2021
CZ29.09.2021
EE29.09.2021
FI29.09.2021
HR29.09.2021
LT29.09.2021
LV29.09.2021
PL29.09.2021
RO29.09.2021
RS29.09.2021
SE29.09.2021
SK29.09.2021
BG29.12.2021
NO29.12.2021
GR30.12.2021
IS29.01.2022
PT31.01.2022
Former [2022/23]AT29.09.2021
CZ29.09.2021
EE29.09.2021
FI29.09.2021
HR29.09.2021
LT29.09.2021
LV29.09.2021
PL29.09.2021
RS29.09.2021
SE29.09.2021
SK29.09.2021
BG29.12.2021
NO29.12.2021
GR30.12.2021
PT31.01.2022
Former [2022/21]AT29.09.2021
FI29.09.2021
HR29.09.2021
LT29.09.2021
LV29.09.2021
RS29.09.2021
SE29.09.2021
BG29.12.2021
NO29.12.2021
GR30.12.2021
Former [2022/10]FI29.09.2021
HR29.09.2021
LT29.09.2021
LV29.09.2021
RS29.09.2021
SE29.09.2021
BG29.12.2021
NO29.12.2021
GR30.12.2021
Former [2022/09]FI29.09.2021
LT29.09.2021
RS29.09.2021
SE29.09.2021
BG29.12.2021
NO29.12.2021
Former [2022/08]FI29.09.2021
LT29.09.2021
SE29.09.2021
BG29.12.2021
NO29.12.2021
Former [2022/07]LT29.09.2021
NO29.12.2021
Documents cited:Search[X]WO0237113  (GIESING MICHAEL [DE], et al);
 [X]EP2503009  (ZOLLO MASSIMO [IT]);
 [X]WO2013009632  (UNIV UTAH RES FOUND [US], et al);
 [X]US2013149704  (JEWELL SUSAN [US], et al);
 [X]WO2015023553  (BIONUMERIK PHARMACEUTICALS INC [US]);
by applicantWO0017390
 WO2015118077
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.